Insider · CIK 0001944119
Kevin Feeley
cfoofficer
Files at WGS (GeneDx Holdings Corp.). First filing Oct 31, 2024, latest Sep 18, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 38
$0 bought, $15M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WGS: GeneDx Holdings Corp.
WGSOct 9, 2026 · close 67.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | GeneDx Holdings Corp. | $364k 3,728 shares | -8% | - | |
| 25Weak | GeneDx Holdings Corp. | $108k 1,285 shares | -3% | - | |
| 20Weak | GeneDx Holdings Corp. | $31k 372 shares | -1% | - | |
| 31Weak | WGSsell GeneDx Holdings Corp. | $557k 8,818 shares | -20% | +9% from low-63% from high | |
| 29Weak | WGSsell GeneDx Holdings Corp. | $438k 5,706 shares | -17% | +35% from low-55% from high | |
| 17Weak | WGSsell GeneDx Holdings Corp. | $111k 1,280 shares | -6% | +68% from low-44% from high | |
| 45Moderate | WGSsell GeneDx Holdings Corp. | $486k 6,187 shares | -25% | +41% from low-53% from high | |
| 7Weak | WGSsell GeneDx Holdings Corp. | $22k 287 shares | -3% | +32% from low-56% from high | |
| 20Weak | GeneDx Holdings Corp. | $30k 317 shares | -3% | +74% from low-41% from high | |
| 44Moderate | GeneDx Holdings Corp. | $555k 3,855 shares | -31% | +151% from low-15% from high | |
| 32Weak | GeneDx Holdings Corp. | $202k 1,266 shares | -19% | +185% from low-4% from high | |
| 29Weak | GeneDx Holdings Corp. | $61k 377 shares | -8% | +190% from low-2% from high | |
| 22Weak | GeneDx Holdings Corp. | $53k 388 shares | -9% | +134% from low-4% from high | |
| 36Weak | GeneDx Holdings Corp. | $716k 6,609 shares | -66% | +154% from low-19% from high | |
| 42Moderate | GeneDx Holdings Corp. | $453k 3,728 shares | -30% | +229% from low-8% from high | |
| 38Weak | GeneDx Holdings Corp. | $163k 1,272 shares | -19% | +257% from low-5% from high | |
| 29Weak | GeneDx Holdings Corp. | $48k 378 shares | -8% | +264% from low-1% from high | |
| 21Weak | GeneDx Holdings Corp. | $41k 388 shares | -9% | +160% from low-22% from high | |
| 33Weak | GeneDx Holdings Corp. | $491k 5,278 shares | -61% | +161% from low-21% from high | |
| 25Weak | GeneDx Holdings Corp. | $122k 1,344 shares | -15% | +156% from low-23% from high | |
| 38Weak | GeneDx Holdings Corp. | $242k 3,729 shares | -30% | +90% from low-43% from high | |
| 29Weak | GeneDx Holdings Corp. | $92k 1,266 shares | -19% | +105% from low-38% from high | |
| 20Weak | GeneDx Holdings Corp. | $26k 370 shares | -8% | +110% from low-37% from high | |
| 40Moderate | GeneDx Holdings Corp. | $1.3M 14,270 shares | -83% | +176% from low-14% from high | |
| 26Weak | GeneDx Holdings Corp. | $44k 388 shares | -10% | +232% from low0% from high | |
| 40Moderate | GeneDx Holdings Corp. | $1.4M 15,516 shares | -90% | +176% from low-14% from high | |
| 48Moderate | GeneDx Holdings Corp. | $836k 8,746 shares | -35% | +174% from low-14% from high | |
| 51Moderate | GeneDx Holdings Corp. | $399k 4,151 shares | -76% | - | |
| 29Weak | GeneDx Holdings Corp. | $87k 922 shares | -14% | - | |
| 20Weak | GeneDx Holdings Corp. | $27k 261 shares | -6% | - | |
| 15Weak | GeneDx Holdings Corp. | $22k 275 shares | -9% | - | |
| 40Moderate | GeneDx Holdings Corp. | $3.3M 35,506 shares | -93% | - | |
| 20Weak | GeneDx Holdings Corp. | $109k 1,430 shares | -5% | - | |
| 34Weak | GeneDx Holdings Corp. | $286k 3,728 shares | -12% | - | |
| 24Weak | GeneDx Holdings Corp. | $87k 1,137 shares | -4% | - | |
| 22Weak | GeneDx Holdings Corp. | $21k 263 shares | -1% | - | |
| 52Moderate | GeneDx Holdings Corp. | $1.6M 22,000 shares | -49% | - | |
| 22Weak | GeneDx Holdings Corp. | $18k 274 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +7,197 | $0.00 | $0 | 48,673 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -586 | $94.26 | $55k | 48,087 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -52 | $95.41 | $4,961 | 48,035 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -541 | $96.90 | $52k | 47,494 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,470 | $98.27 | $144k | 46,024 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,079 | $99.00 | $107k | 44,945 | 24 d ago |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 14,393 | 24 d ago |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 42,761 | 31 d ago |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,285 | $84.22 | $108k | 41,476 | 31 d ago |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 2,463 | 31 d ago |
| Sep 1, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +717 | $0.00 | $0 | 40,671 | 39 d ago |
| Sep 1, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -372 | $83.84 | $31k | 40,299 | 39 d ago |
| Sep 1, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -717 | $0.00 | $0 | 0 | 39 d ago |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +16,250 | $0.00 | $0 | 43,398 | Mar 30, 2026 |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,485 | $61.29 | $152k | 40,913 | Mar 30, 2026 |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -961 | $62.33 | $60k | 39,952 | Mar 30, 2026 |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,520 | $63.28 | $159k | 37,432 | Mar 30, 2026 |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -995 | $64.60 | $64k | 36,437 | Mar 30, 2026 |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,857 | $65.21 | $121k | 34,580 | Mar 30, 2026 |
| Mar 26, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -16,250 | $0.00 | $0 | 32,500 | Mar 30, 2026 |
| Mar 15, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,815 | $0.00 | $0 | 25,657 | Mar 17, 2026 |
| Mar 16, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +7,197 | $0.00 | $0 | 32,854 | Mar 17, 2026 |
| Mar 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,384 | $76.35 | $182k | 30,470 | Mar 17, 2026 |
| Mar 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,065 | $77.05 | $236k | 27,405 | Mar 17, 2026 |
| Mar 16, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -257 | $77.94 | $20k | 27,148 | Mar 17, 2026 |
| Mar 15, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,815 | $0.00 | $0 | 11,446 | Mar 17, 2026 |
| Mar 16, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 28,787 | Mar 17, 2026 |
| Mar 9, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 23,122 | Mar 11, 2026 |
| Mar 9, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,280 | $86.75 | $111k | 21,842 | Mar 11, 2026 |
| Mar 9, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 7,387 | Mar 11, 2026 |
| Mar 6, 2026 | WGS GeneDx Holdings Corp. | AGrant or award Class A Common Stock | +1,986 | $88.11 | $175k | 20,660 | Mar 9, 2026 |
| Mar 3, 2026 | WGS GeneDx Holdings Corp. | AGrant or award Class A Common Stock | +15,262 | $0.00 | $0 | 24,861 | Mar 5, 2026 |
| Mar 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,424 | $77.63 | $111k | 23,437 | Mar 5, 2026 |
| Mar 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,543 | $78.61 | $200k | 20,894 | Mar 5, 2026 |
| Mar 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2,220 | $79.25 | $176k | 18,674 | Mar 5, 2026 |
| Mar 3, 2026 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +10,865 | $0.00 | $0 | 10,865 | Mar 5, 2026 |
| Mar 1, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +718 | $0.00 | $0 | 9,886 | Mar 3, 2026 |
| Mar 2, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -287 | $77.52 | $22k | 9,599 | Mar 3, 2026 |
| Mar 1, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -718 | $0.00 | $0 | 1,434 | Mar 3, 2026 |
| Jan 29, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +754 | $0.00 | $0 | 9,485 | Feb 2, 2026 |
| Jan 29, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -315 | $94.00 | $30k | 9,170 | Feb 2, 2026 |
| Jan 29, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -2 | $92.06 | $184 | 9,168 | Feb 2, 2026 |
| Jan 29, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -754 | $0.00 | $0 | 754 | Feb 2, 2026 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +7,197 | $0.00 | $0 | 12,586 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -131 | $138.93 | $18k | 12,455 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -366 | $140.08 | $51k | 12,089 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -951 | $141.20 | $134k | 11,138 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -215 | $142.12 | $31k | 10,923 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -334 | $144.27 | $48k | 10,589 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -578 | $145.36 | $84k | 10,011 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -699 | $146.93 | $103k | 9,312 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -331 | $148.55 | $49k | 8,981 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -97 | $149.20 | $14k | 8,884 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -26 | $150.75 | $3,920 | 8,858 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -127 | $140.45 | $18k | 8,731 | Dec 18, 2025 |
| Dec 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 35,984 | Dec 18, 2025 |
| Dec 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 6,655 | Dec 11, 2025 |
| Dec 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,266 | $159.28 | $202k | 5,389 | Dec 11, 2025 |
| Dec 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 9,849 | Dec 11, 2025 |
| Dec 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +717 | $0.00 | $0 | 4,570 | Dec 3, 2025 |
| Dec 1, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -377 | $162.54 | $61k | 4,193 | Dec 3, 2025 |
| Dec 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -717 | $0.00 | $0 | 2,152 | Dec 3, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +753 | $0.00 | $0 | 4,145 | Oct 31, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -388 | $136.54 | $53k | 3,757 | Oct 31, 2025 |
| Oct 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -753 | $0.00 | $0 | 1,508 | Oct 31, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock10b5-1 | +1,246 | $32.67 | $41k | 10,001 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -344 | $105.24 | $36k | 9,657 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -387 | $106.86 | $41k | 9,270 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,715 | $107.68 | $292k | 6,555 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,152 | $108.67 | $234k | 4,403 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -421 | $110.05 | $46k | 3,982 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -520 | $111.93 | $58k | 3,462 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -70 | $113.68 | $7,958 | 3,392 | Oct 1, 2025 |
| Sep 30, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -1,246 | $0.00 | $0 | 4,982 | Oct 1, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | -7,197 | $0.00 | $0 | 12,483 | Sep 18, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +7,197 | $0.00 | $0 | 12,483 | Sep 18, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,728 | $121.47 | $453k | 8,755 | Sep 18, 2025 |
| Sep 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 43,181 | Sep 18, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 6,558 | Sep 11, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,266 | $128.05 | $162k | 5,292 | Sep 11, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -6 | $129.09 | $775 | 5,286 | Sep 11, 2025 |
| Sep 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 12,311 | Sep 11, 2025 |
| Sep 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +717 | $0.00 | $0 | 4,474 | Sep 3, 2025 |
| Sep 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -378 | $125.81 | $48k | 4,096 | Sep 3, 2025 |
| Sep 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -717 | $0.00 | $0 | 2,869 | Sep 3, 2025 |
| Jul 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +753 | $0.00 | $0 | 4,145 | Jul 31, 2025 |
| Jul 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -388 | $105.31 | $41k | 3,757 | Jul 31, 2025 |
| Jul 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -753 | $0.00 | $0 | 2,261 | Jul 31, 2025 |
| Jul 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock10b5-1 | +1,245 | $32.67 | $41k | 8,670 | Jul 11, 2025 |
| Jul 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,278 | $93.00 | $491k | 3,392 | Jul 11, 2025 |
| Jul 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -1,245 | $0.00 | $0 | 6,228 | Jul 11, 2025 |
| Jul 1, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -998 | $90.86 | $91k | 7,771 | Jul 3, 2025 |
| Jul 1, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -346 | $91.88 | $32k | 7,425 | Jul 3, 2025 |
| Jun 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | -7,197 | $0.00 | $0 | 12,498 | Jun 18, 2025 |
| Jun 16, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,729 | $64.77 | $242k | 8,769 | Jun 18, 2025 |
| Jun 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 50,378 | Jun 18, 2025 |
| Jun 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 6,567 | Jun 11, 2025 |
| Jun 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,266 | $72.55 | $92k | 5,301 | Jun 11, 2025 |
| Jun 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 14,773 | Jun 11, 2025 |
| Jun 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +718 | $0.00 | $0 | 4,475 | Jun 3, 2025 |
| Jun 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -370 | $71.26 | $26k | 4,105 | Jun 3, 2025 |
| Jun 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -718 | $0.00 | $0 | 3,586 | Jun 3, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock10b5-1 | +1,246 | $32.67 | $41k | 17,242 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -637 | $83.67 | $53k | 16,605 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,198 | $84.61 | $101k | 15,407 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,171 | $85.73 | $100k | 14,236 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -249 | $86.48 | $22k | 13,987 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,993 | $93.28 | $559k | 7,994 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,693 | $94.61 | $255k | 5,301 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,463 | $95.53 | $140k | 3,838 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -846 | $96.46 | $82k | 2,992 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -20 | $97.26 | $1,945 | 2,972 | May 9, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -1,246 | $0.00 | $0 | 7,473 | May 9, 2025 |
| Apr 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +753 | $0.00 | $0 | 3,725 | May 1, 2025 |
| Apr 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -388 | $113.09 | $44k | 3,337 | May 1, 2025 |
| Apr 30, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Class A Common Stock | +420 | $56.82 | $24k | 3,757 | May 1, 2025 |
| Apr 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -753 | $0.00 | $0 | 3,014 | May 1, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock10b5-1 | +1,246 | $32.67 | $41k | 17,242 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -637 | $83.67 | $53k | 16,605 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,198 | $84.61 | $101k | 15,407 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,171 | $85.73 | $100k | 14,236 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -249 | $86.48 | $22k | 13,987 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -6,810 | $93.26 | $635k | 7,177 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,122 | $94.60 | $295k | 4,055 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,463 | $95.53 | $140k | 2,592 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -846 | $96.46 | $82k | 1,746 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -20 | $97.26 | $1,945 | 1,726 | Apr 10, 2025 |
| Apr 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -1,246 | $0.00 | $0 | 7,473 | Apr 10, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +16,250 | $0.00 | $0 | 24,742 | Mar 28, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -8,418 | $95.66 | $805k | 16,324 | Mar 28, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -328 | $94.40 | $31k | 15,996 | Mar 28, 2025 |
| Mar 26, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -16,250 | $0.00 | $0 | 48,750 | Mar 28, 2025 |
| Mar 13, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -402 | $90.05 | $36k | 5,044 | Mar 17, 2025 |
| Mar 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | -7,197 | $0.00 | $0 | 12,241 | Mar 17, 2025 |
| Mar 17, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,749 | $96.71 | $363k | 8,492 | Mar 17, 2025 |
| Mar 26, 2024 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +65,000 | $0.00 | $0 | 65,000 | Mar 17, 2025 |
| Mar 15, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +15,261 | $0.00 | $0 | 15,261 | Mar 17, 2025 |
| Mar 16, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 57,575 | Mar 17, 2025 |
| Mar 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 6,368 | Mar 11, 2025 |
| Mar 10, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -922 | $94.72 | $87k | 5,446 | Mar 11, 2025 |
| Mar 9, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 17,235 | Mar 11, 2025 |
| Mar 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +717 | $0.00 | $0 | 4,167 | Mar 4, 2025 |
| Mar 3, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -261 | $103.94 | $27k | 3,906 | Mar 4, 2025 |
| Mar 1, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -717 | $0.00 | $0 | 4,034 | Mar 4, 2025 |
| Jan 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +753 | $0.00 | $0 | 3,225 | Jan 31, 2025 |
| Jan 29, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -275 | $78.48 | $22k | 2,950 | Jan 31, 2025 |
| Jan 29, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -753 | $0.00 | $0 | 3,767 | Jan 31, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +11,208 | $32.67 | $366k | 37,978 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -24,073 | $93.32 | $2.2M | 13,905 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -7,078 | $94.28 | $667k | 6,827 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,455 | $95.62 | $330k | 3,372 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -900 | $96.52 | $87k | 2,472 | Jan 10, 2025 |
| Jan 7, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Employee Stock Option (Right to Buy)derivative | -11,208 | $0.00 | $0 | 8,719 | Jan 10, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -319 | $75.08 | $24k | 27,881 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -774 | $76.00 | $59k | 27,107 | Jan 6, 2025 |
| Jan 2, 2025 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -337 | $77.04 | $26k | 26,770 | Jan 6, 2025 |
| Dec 16, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +7,197 | $0.00 | $0 | 31,928 | Dec 18, 2024 |
| Dec 16, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -3,728 | $76.75 | $286k | 28,200 | Dec 18, 2024 |
| Dec 16, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -7,197 | $0.00 | $0 | 64,772 | Dec 18, 2024 |
| Dec 9, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +2,462 | $0.00 | $0 | 25,868 | Dec 11, 2024 |
| Dec 9, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,137 | $76.37 | $87k | 24,731 | Dec 11, 2024 |
| Dec 9, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -2,462 | $0.00 | $0 | 19,697 | Dec 11, 2024 |
| Dec 1, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +718 | $0.00 | $0 | 23,669 | Dec 3, 2024 |
| Dec 2, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -263 | $78.39 | $21k | 23,406 | Dec 3, 2024 |
| Dec 1, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -718 | $0.00 | $0 | 5,021 | Dec 3, 2024 |
| Nov 21, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -200 | $69.58 | $14k | 44,751 | Nov 25, 2024 |
| Nov 21, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -430 | $70.84 | $30k | 44,321 | Nov 25, 2024 |
| Nov 21, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -969 | $71.86 | $70k | 43,352 | Nov 25, 2024 |
| Nov 21, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,057 | $73.00 | $77k | 42,295 | Nov 25, 2024 |
| Nov 21, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,524 | $73.79 | $408k | 36,771 | Nov 25, 2024 |
| Nov 21, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -3,839 | $74.97 | $288k | 32,932 | Nov 25, 2024 |
| Nov 22, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -5,162 | $75.34 | $389k | 27,770 | Nov 25, 2024 |
| Nov 22, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,711 | $76.41 | $207k | 25,059 | Nov 25, 2024 |
| Nov 22, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -2,108 | $77.40 | $163k | 22,951 | Nov 25, 2024 |
| Oct 29, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +753 | $0.00 | $0 | 45,225 | Oct 31, 2024 |
| Oct 29, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -274 | $66.60 | $18k | 44,951 | Oct 31, 2024 |
| Oct 29, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -753 | $0.00 | $0 | 4,520 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.